References
Finsterer J, Zarrouk-Mahjoub S (2017) Affection of immune cells by a C10orf2 mutation manifesting as mitochondrial myopathy and transient sensory transverse syndrome. Acta Neurol Belg. doi:10.1007/s13760-017-0821-8
Galassi G, Maggi L, Lamantea L, Ariatti A, Malagoli M (2017) C10ORF2 mutation associated with progressive external ophthalmoplegia and clinically isolated syndrome. Acta Neurol Belg. doi:10.1007/s13760-017-0793-8
Cotton F, Weiner HL, Jolesz FA, Guttmann CR (2003) MRI contrast uptake in new lesions in relapsing—remitting MS followed at weekly intervals. Neurology 25:640–646
Swanton JK, Ferrnando K, Dalton CM, Miszkiel KA, Thompson AJ, Plant GT et al (2006) Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 77:830–833
Gropman AL (2013) Neuroimaging in mitochondrial disorders. Neurotherapeutics 10:273–285
Horwitz H, Degn M, Modvig S, Larsson HB, Wanscher B, Frederiksen JL (2012) CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis. J Neurol 259:2616–2620
Hardmaier M, Leocani L, Fuhr P (2017) A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials. Mult Scler. doi:10.1177/1352458517707265
Martinelli V, Dalla Costa G, Messina MJ, Di Maggio G, Sangalli F, Moiola L et al (2017) Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndrome. Acta Neurol Scand. doi:10.1111/ane.12761
Bourre MD, Zéphir H, Ongagna JC, Cordonnier C, Collongues N, Debette S et al (2012) Long term follow up of acute partial transverse myelitis. Arch Neurol 69:357–362
Gaetani L, Mignarri A, Di Gregorio M, Sarchielli P, Malandrini A, Cardaioli E et al (2016) Multiple sclerosis and chronic progressive external ophthalmoplegia associated with large scale mitochondrial DNA single deletion. J Neurol 263:1449–1451
Sadeghian M, Mastrolia V, Haddad AR, Mosley A, Mullali G, Schiza D et al (2016) Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis. Sci Rep 6:33249. doi:10.1038/srep33249
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Galassi, G., Maggi, L., Lamantea, E. et al. Reply to the letter by Finsterer et al. concerning the paper: “Affection of immune-cells by a C10orf2 mutation manifesting as mitochondrial myopathy and transient sensory transverse syndrome” by Galassi G. et al.. Acta Neurol Belg 117, 971–972 (2017). https://doi.org/10.1007/s13760-017-0822-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-017-0822-7